Federal Appeals Court Overturns $223 Million Jury Award in Johnson & Johnson Talc-Related Cancer Case
The federal appeals court has overturned a $223 million jury award in a case where New Jersey residents claimed they developed cancer from using Johnson & Johnson’s talc-based products, according to reports and a recent ruling. The appellate division of the Superior Court of New Jersey stated that the scientific testimony linking J&J’s products to the cancers was improper and should not have been presented to the jurors. The panel explained that the experts for the plaintiffs failed to provide sufficient explanations for the facts or methods supporting their claims. Erik Haas, Worldwide Vice President … Read more